Tenders Are Invited For Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure

Pharmaceutical Products – Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For Various Active Ingredients/S/Combinations With The Possibility Of Conclusion At Any Time As Part Of The So-Called Open House Procedure. The Subject Of This Publication Is The Conclusion Of Agreements In Accordance With Section 130A Paragraph 8 Sgb V On Various Active Ingredients/Combinations Of Active Ingredients As Part Of A So-Called Open House Procedure. Subject To Uniform Contractual Conditions And A Uniform Access Procedure, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Are Offered The Opportunity To Conclude Or Join A Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient/Combination Of Active Ingredients Mentioned. After Registering, Interested Pharmaceutical Companies Can Download The Order Documents (Participation Documents And Contract) At: Https://Www.Dtvp.De/Satellite/Notice/Cxp4y6m51rv. The Email Address Specified In The Client Section For The Purpose Of Unrestricted And Complete, Free Access To The Order Documents Is No Longer Valid. Information Can Only Be Obtained By Registering On The Dtvp Procurement Platform Under The Communication Tab. Information And Answers Provided By Other Bodies Are Not Binding. The Prerequisite For Concluding A Contract Is That The Interested Pharmaceutical Company Submits The Required Procedural Documents, Completely Completed And Signed. Any Pharmaceutical Company That Meets The Participation Requirements And Documents This By Signing The Declarations And The Discount Agreement Can Join The Discount Agreement. New: The Option Of A Qualified Electronic Signature Via Fp Sign Is Now Also Offered. For Further Information, Please Refer To The Procedural Information Form. There Is No Exclusivity. Joining Or Concluding A Contract Can Take Place At Any Time And Under The Same Conditions. Individual Contract Negotiations Will Not Be Carried Out. The Contract Can Only Begin On The First Of Each Month. The Earliest Contract Start Date Is December 1St, 2025. Based On This, The Contract Term Is A Maximum Of 23 Months. The Contract Ends On October 31, 2027 At The Latest, Regardless Of The Date The Contract Was Concluded. If The Contract Begins On December 1St, 2025, The Offer Must Be Available By October 24Th, 2025 At The Latest; However, No Contracts Will Be Concluded By Aok Nordost Before November 4Th, 2025. For A Later Start Of The Contract, The Deadline For Submitting Offers Is The 5Th Of The Previous Month. (Example: Contract Start January 1St, 2026; Deadline For Submitting The Offer: December 5Th, 2025). Should Aok Nordost Award An Exclusive Contract For The Active Ingredient/Combination Of Active Ingredients During An Open Procedure During The Contract Term, The Contractual Provisions Concluded In This Publication Apply. This Publication Does Not Involve The Award Of A Public Contract Within The Meaning Of The Procurement Coordination Directive 2014/24/Eu Of The European Parliament And Of The Council Or Public Procurement Law. Um